Glabio Pharma Private Limited
About Glabio Pharma Private Limited
Data last updated:
Glabio Pharma Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India. It was incorporated on 19 November 2023.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U46497TZ2023PTC029946.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Pichai Hussain Mohammed Yusuff and Mohanan Akil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Coimbatore, Tamil Nadu.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Glabio Pharma Private Limited's registered office is in Coimbatore, Tamil Nadu.
- Registered AddressS.F.No4/216/1 Sun Garden, Edayarpalayam, Coimbatore, Tamil Nadu, India – 641008
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Glabio Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Glabio Pharma Private Limited, buy the company report.
Board of directors of Glabio Pharma Private Limited
Glabio Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pichai Hussain Mohammed Yusuff | Director | 19 Nov 2023 | 2 Years 11 Months | Current |
| Mohanan Akil | Director | 19 Nov 2023 | 2 Years 11 Months | Current |
| Moideen Haja Hussain Jainudeen | Director | 19 Nov 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Glabio Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glabio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glabio Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glabio Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Mohanan Akil was appointed as Director on 19 Nov 2023.
Frequently asked questions
Glabio Pharma is an active private limited company based in Coimbatore, Tamil Nadu, India. It was incorporated on 19 November 2023 (3+ years old) and is registered under CIN U46497TZ2023PTC029946.
Glabio Pharma has 3 current directors:
- Pichai Hussain Mohammed Yusuff - Director
- Mohanan Akil - Director
- Moideen Haja Hussain Jainudeen - Director
The latest financial statements of Glabio Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Glabio Pharma is U46497TZ2023PTC029946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glabio Pharma was incorporated on 19 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Coimbatore.
Mohanan Akil was appointed as Director on 19 Nov 2023. Moideen Haja Hussain Jainudeen was appointed as Director on 19 Nov 2023. Pichai Hussain Mohammed Yusuff was appointed as Director on 19 Nov 2023.
The registered office of Glabio Pharma is at S.F.No42161 Sun Garden, Edayarpalayam, Coimbatore, Tamil Nadu, India – 641008.
The compliance status of Glabio Pharma is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.
Glabio Pharma can be reached at its registered office: S.F.No42161 Sun Garden, Edayarpalayam, Coimbatore, Tamil Nadu, India – 641008.
Glabio Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Coimbatore.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
